Destruction of rainforests through wildfires or deforestation may harm human health. As these forests disappear, we may be losing precious medicinal plants that hold treatments for various diseases.
Academic rigor, journalistic flair
Articles on Drug resistance
Displaying 21 - 40 of 51 articles
As antibiotic resistance increases globally, the heat is on to find new alternatives to treat infections. Chemists can get a head start by looking at compounds produced in nature by fishes’ microbes.
Gene sequences can be manipulated to prevent certain diseases and improve public health.
Using a large number of computers to screen TB drugs reduces the cost and time.
Cancer is the second leading cause of death globally. Mathematicians have joined the fight, developing models to both test cancer drug combinations and understand chemotherapy drug resistance.
Malaria is a major public health problem that affects 106 countries globally. A rigorous and systematic approach to predict and control malaria transmission is needed.
New genetic technologies are letting us look at flu evolution right where it starts: within individual people, while they’re sick.
Genetic analysis is getting cheaper and can provide real-time surveillance of drug resistance.
Eliminating malaria in Africa has been held back by a range of factors, including a lack of funds and drug and insecticide resistance challenges.
The gains made towards eliminating malaria in endemic countries is being threatened by insecticide and antimalarial drug resistance.
Up to 50% of the people who take the efavirenz antiretroviral react particularly badly to it and need to change drug regimens.
A global trend to regulate frequent antibiotic use in livestock and poultry production is emerging but Africa is still lagging behind.
Antimicrobial resistance continues to be a growing concern for our future health. Whose responsibility is it to intervene?
A new study shows that by using genomics, you can cut down the lengthy process of testing for drug-resistance TB to a matter of days.
South African scientists have found a way to single out the problematic parts of the bacteria causing TB that results in drug resistance.
Resistance to a commonly used antimalarial medication, Atovaquone, can’t spread to the general human population, a new research found.
Many people in the U.S. have no idea that TB is still found here, or what a major health risk it poses in other parts of the world.
There is an increasing focus on alternative treatment strategies, developed to treat other diseases and conditions but re-purposed to tackle TB.
Although there have been global efforts to eliminate parasites, some parasites and vectors will have survived attack because they have evolved resistance.
More than 700,000 people die each year from antibiotic-resistant infections. The World Health Organisation is trying to end the age of ignorance to protect this global common good.
Top contributors
-
Associate Professor, SARChI Research Chair in Mycobactomics, Stellenbosch University
-
Chief Research Officer, Kenya Medical Research Institute
-
Director of Science, Ifakara Health Institute
-
Principal Research Scientist, National Institute for Medical Research (NIMR)
-
Professor of Public Health, Bond University
-
Senior Research Scientist & Head of Antiviral Sensitivity Analysis, WHO Collaborating Centre for Reference and Research on Influenza
-
Professor, ithree institute, University of Technology Sydney
-
Professor in Infectious Diseases, Queensland Institute of Medical Research
-
Professor of Molecular Parasitology and Medicine, St George's, University of London
-
Senior Principal Research Scientist, Ecosystem Sciences, CSIRO
-
Co-head, Gilson/Crabb Laboratory & Senior Research Officer, Burnet Institute
-
Associate Member, Fred Hutchinson Cancer Research Center and Affiliate Associate Professor of Genome Sciences and Microbiology, University of Washington
-
Postdoctoral Fellow in Bioinformatics, University of the Western Cape
-
Senior lecturer, Newcastle University
-
Associate Professor (Biochemistry) DST/NRF South African Research Chair (SARChI) in Sustainable Malaria Control, University of Pretoria
